Ben Bowen, William Albright, Ben Bulkley, Bernd Brust, John Radak, Kelli Richard

Jan 05, 2007

Premium

Ben Bowen has been appointed vice president of business development at Biolog.

Bowen will be responsible for launching Biolog’s forthcoming mammalian cell Phenotype Microarray product. Previously, Bowen served as vice president of discovery research at Lynx Therapeutics. He has also worked at Pioneer Hi-Bred (now part of DuPont).

ForteBio this week named William Albright as the company’s chief financial officer.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

The Scan

Retirement Moves

The US National Institutes of Health has developed guidelines to gauge whether frail chimpanzees are healthy enough to be moved to a retirement sanctuary.

Osamu Shimomura Dies

Osamu Shimomura, who won the 2008 Nobel Prize in Chemistry for his work on green fluorescent protein, has died.

This Week in PLOS

In PLOS this week: analytical approach for finding new genetic associations, analysis of Streptococcus pyogenes-infecting viruses, and more.

Shuffle at IBM Watson Health

Stat News reports that the head of IBM Watson Health is leaving her post.

Main menu